Aytu Biopharma Inc (AYTU)

Überblick Nachrichten Preisverlauf Financials Warum fällt AYTU? Forum Prognose Aktiensplit

Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	13.75% 18.45	16.22	16.57	17.98	17.99
Cost Of Revenue	3.88% 5.646	5.435	4.589	6.07	6.30
Gross Profit	18.73% 12.81	10.79	11.98	11.91	11.69
Operating Expenses	16.79% 10.38	12.48	12.91	15.56	14.16
Benefits Costs and Expenses	7.61% 14.63	15.84	15.08	21.90	20.64
Costs And Expenses	7.61% 14.63	15.84	15.08	21.90	20.64
Operating Income/Loss	242.83% 2.421	-1.695	-0.93	-3.65	-2.464
Income/Loss From Continuing Operations Before Tax	899.48% 3.818	0.382	1.498	-3.922	-2.642
Income Tax Expense/Benefit	56.89% -0.122	-0.283	0.405	0.695	0.245
Income/Loss From Continuing Operations After Tax	492.48% 3.94	0.665	1.093	-4.617	-2.887
Income/Loss From Discontinued Operations, Net Of Tax	56.10% 0.054	0.123	0.381	-	-
Net Income/Loss	406.85% 3.994	0.788	1.474	-4.617	-2.887
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.04% 6.1346	6.1321	6.068	0.0269	5.5336
Diluted Average Shares	3.31% 8.2045	8.4851	9.0996	-	-
Basic Earnings Per Share	400.00% 0.65	0.13	0.24	-0.82	-0.52
Diluted Earnings Per Share	180.77% 0.21	-0.26	-0.15	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$28.92

3.60%

ELAN

$17.47

0.69%

RDY

$14.15

0.28%

VTRS

$10.33

2.09%

NBIX

$140.40

3.15%

UTHR

$380.47

2.80%